Biochemical Engineering XVI: Past, Present, and Future. Held in Burlington, VT from July 5-9, 2009

首席调查员将汇集知名的研究人员、年轻的研究人员、私营部门的科学家和工程师以及研究生，以评估不断变化的生化工程领域的现状并绘制未来的图表。上届生化工程会议(XV：加拿大魁北克市，2007年7月15日至19日)有来自24个国家的252名与会者参加，其中58%是学术界，34%是工业界，8%是其他(研究所等)。通过全体报告、口头会议和海报会议，BioChE XVI将探讨一些新兴和成熟的主题，并在小型会议氛围中进行高级别讨论和参与。更广泛的影响生物化学工程XVI将全面介绍目前生化工程面临的挑战和未来的发展方向。生物技术领域的主题选择-分子设计和展示、细胞-材料界面、生物燃料和生物能源、疫苗、纳米技术、代谢工程、持续生物加工、生化网络的定量分析和工程、干细胞生物工程以及干细胞生物工程与生化工程的核心领域(下游加工、蛋白质稳定性和工程、过程开发和细胞培养)相结合，将对未来十年生物技术的发展方向产生深远的影响。私人投资促进机构还做出重大努力，邀请和招募在科学和工程学中代表性较低的群体的演讲者和会议主席。在15个口头会议中，有11个包括至少一名来自学术界或工业界的女性演讲者。NSF为会议提供的资金将支持女性和代表不足的少数族裔演讲者以及来自美国学术机构的学生。

0936044RobinsonIntellectual MeritFor this premier international conference, which is the sixteenth edition in the series, the Principal Investigators will bring together established researchers, young investigators, private sector scientists and engineers, and graduate students to assess the present and chart the future of the ever-changing field of biochemical engineering. The last Biochemical Engineering conference (XV: Quebec City, Canada, July 15-19, 2007) was attended by 252 participants from 24 countries, with 58% academia, 34% industrial, and 8% other (institutes, etc). With plenary presentations, oral sessions, and poster sessions, BioChE XVI will explore a number of emerging and established subjects with a small conference atmosphere that enables high-level discussion and participation. Broader ImpactsBiochemical Engineering XVI will provide comprehensive coverage of present challenges and future directions in biochemical engineering. The choice of topics across the biotechnology field - molecular design and display, the cell-materials interface, biofuels and bioenergy, vaccines, nanotechnology, metabolic engineering, continuous bioprocessing, and quantitative analysis and engineering of biochemical networks, and stem cell bioengineering in combination with core areas of biochemical engineering (downstream processing, protein stability and engineering, process development, and cell culture) will have a profound impact on the direction of biotechnology over the next ten years.The PIs have also made a significant effort to invite and recruit speakers and session chairs from groups underrepresented in science and engineering. Eleven of the fifteen oral sessions include at least one female speaker from academia or industry. NSF funds provided for the meeting will support female and underrepresented minority speakers and students from US academic institutions.